Yahoo Search Búsqueda en la Web

Entrar

  1. Anuncio

    relacionado con: Optimizing Chemotherapy Emmett Miller
  2. sigmaaldrich.com

    Complex-based photoactivated chemotherapy

    Act Now

    Best-in-class lab materials, technologies & services to help you complete your research. Expertise on every level to craft science & technology solutions in life science.

    Superior Customer Service · Tech service & Support · Filtration · World-Class Expertise

    • Services Offered

      Wide variety of services related to

      products, processes, industries.

    • Sign In

      Sigma® Life Science

      View contract pricing, get quotes

Resultado de búsqueda

  1. www.nejm.org › doi › fullPerioperative Nivolumab in Resectable Lung Cancer | NEJM

    15 de may. de 2024 · Background. Standard treatment with neoadjuvant nivolumab plus chemotherapy significantly improves outcomes in patients with resectable non–small-cell lung cancer (NSCLC). Perioperative ...

  2. aacrjournals.org › PO4/02/11 › 744082Abstract PO4-02-11: Optimizing Taxane-based Chemotherapy in...

    2 de may. de 2024 · Optimizing Taxane-based Chemotherapy in Breast Cancer: Retrospective study comparing 4 cycles of TC to 6 cycles of TC [abstract]. In: Proceedings of the 2023 San Antonio Breast Cancer Symposium; 2023 Dec 5-9; San Antonio, TX.

  3. www.cancertreatmentreviews.com › article › S0305-7372(24)00095-1Optimizing care in early phase cancer trials: The role of...

    Hace 4 días · In January 2022, there were an estimated 18 million people with a history of cancer living in the United States [1]. As a result of the introduction of novel targeted therapies and immunotherapies, as well as the growth of screening for multiple cancer types, more people are living long lives after a diagnosis of cancer [2]. While this represents encouraging progress in the treatment of cancer ...

  4. Imágenes

    • Optimizing Chemotherapy with Dr. Emmett Miller – BetterListen!
    • Optimizing Chemotherapy, Emmett Miller | 9781615448340 | Boeken | bol.com
    • Optimizing Chemotherapy with Dr. Emmett Miller – BetterListen!
    • Optimizing Chemotherapy with Dr. Emmett Miller – BetterListen!
    • Optimizing Chemotherapy with Dr. Emmett Miller – BetterListen!

    Ver todo

  5. aacrjournals.org › clincancerres › articleUnraveling the Therapeutic Benefit of Sequenced...

    1 de may. de 2024 · Summary. Combination immune-checkpoint inhibition with chemotherapy is a clinical standard, yet concurrent administration may limit the full benefit of immunotherapy by blunting the proliferation and differentiation of CD8 T cells. Identifying patients in whom sequential chemo-immunotherapy or immunotherapy alone is feasible should ...

  6. bmccancer.biomedcentral.com › articles › 10Efficacy and safety of different chemotherapy regimens concurrent...

    15 de may. de 2024 · Bin Dong & Yongchun Zhang. BMC Cancer 24, Article number: 589 ( 2024 ) Cite this article. Metrics. Abstract. Background. Evaluate the efficacy and safety of different chemotherapy regimens concurrent with radiotherapy in treating locally advanced cervical cancer (LACC). Methods.

  7. Videos

    Ver todo

  8. aacrjournals.org › 30/9/1833 › 743132Platinum-Based Chemotherapy Attenuates the Effector Response of...

    1 de may. de 2024 · Platinum-Based Chemotherapy Attenuates the Effector Response of CD8 T Cells to Concomitant PD-1 Blockade | Clinical Cancer Research | American Association for Cancer Research. Translational Cancer Mechanisms and Therapy | May 01 2024.

  9. link.springer.com › article › 10Long-term survival after systemic chemotherapy ... - Springer

    14 de may. de 2024 · We describe the use of systemic chemotherapy, chemoradiotherapy, and maintenance therapy in the case of an older adult patient with recurrent PACC harboring a germline BRCA2 variant with a survival of more than 5 years after PACC recurrence.